Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 --- NDC 52343-125-90
Published March 27, 2019 · Recall initiated: March 7, 2019
Summary
FDA records drug Class II recall D-1055-2019, published March 27, 2019 and initiated March 7, 2019. Recalling firm: Rising Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 42,016 bottles; Lot: 473180007A, exp. date 03/31/2020 473180008A, exp. date 03/31/2020 473180011A, exp. date 04/30/2020 473180020B1, exp. date 07/31/2020 473170019B, exp. date 10/31/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Rising Pharmaceuticals, Inc.
- Distributor
- Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.
- Lot
- 473180007A, exp. date 03/31/2020 473180008A, exp. date 03/31/2020 473180011A, exp. date 04/30/2020 473180020B1, exp. date 07/31/2020 473170019B, exp. date 10/31/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATimolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye,July 1, 2020
- FDATimolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by:July 1, 2020
- FDAValsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook,March 27, 2019
- FDADAHlicious ORGANIC Lassi India -Style DRINKABLE YOGURT, Grassland Plain, , 32 FL OZ (946 mL), UPC: 7 93573March 27, 2019
- FDALosartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC:March 27, 2019
- FDADAHlicious ORGANIC LASSI India-Style DRINKABLE YOGURT Golden Turmeric Lassi, 23 FL OZ (946 mL), UPC: 7 93573March 27, 2019
Questions about this recall
Was Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 --- NDC 52343-125-90 recalled?
Yes. FDA published recall D-1055-2019 on March 27, 2019. Reported hazard: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
What should I do if I have this product?
Voluntary: Firm initiated · Letter